Sign in
Enrolling by invitationNo phase

Studying liver fats and proteins in adults with fatty liver disease

Examines which liver fats and proteins are linked to fatty liver disease severity.

Key facts

Who runs it
Vanderbilt University
Where
Nashville, United StatesSee the site
Trial code
Registry title
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
Status
Enrolling by invitation
People taking part
45 people, planned
Started
Oct 2009
Expected to end
Nov 2026
Type of study
Observational, 3 groups
Record updated
18 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 who are having planned abdominal or weight-loss surgery. It studies fats and proteins linked to fatty liver disease.

Age
18 to 65 years
Sex
Women only
Disease stage
Not specified. Liver enzyme levels (ALT/AST) may be normal or raised.
Earlier treatment
People who use any thiazolidinediones cannot join.

Main reasons for not taking part

  • Viral hepatitis
  • Significant alcohol use
  • Current infections
  • Use of any thiazolidinediones

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • 18-65 year of age
  • Undergoing elective abdominal or bariatric surgery
  • May have normal or elevated ALT/AST levels

Who cannot take part

  • Presence of viral hepatitis
  • Intercurrent infections
  • Significant alcohol use
  • Use of any thiazolidinediones

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Vanderbilt University Medical CenterNashville, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in the United States. The incidence of NAFLD is very similar to that of obesity, type 2 diabetes, and the metabolic syndrome. The investigators hypothesize that there may be a relationship between over-nutrition, decreased physical activity and the development of fatty liver. The purpose of this study is to identify the types of fats and proteins, and the quantity of each, that are associated with increased severity of NAFLD.

The 3 groups in the trial

  • Obese, bariatric surgery, liver biopsy

    Obese subjects approved and scheduled for bariatric surgery at Vanderbilt University Medical Center

  • Normal BMI, abdominal surgery, liver biopsy

    Normal weight subjects having elective abdominal surgery at Vanderbilt University Medical Center.

  • Liver transplantation donors and recipients

    All livers made available for implantation or explantation will be eligible.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Relative Abundance and Spatial Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
Plain-language title
Studying liver fats and proteins in adults with fatty liver diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT00983463, who can take part
Record updated
18 December 2025